The tickets could go to the lipid-lowering pill enlicitide decanoate and the antibody-drug conjugate sacituzumab tirumotecan, ...
Novartis has discontinued two undisclosed programs under its current partership with Voyager, the biotech announced last ...
The Greater Philadelphia life sciences ecosystem has over 1,200 life sciences establishments, including 450 biotech research ...
Clarity on employment terms is essential to protect careers. In this column, Kaye/Bassman’s Michael Pietrack speaks to ...
Biotech’s slump may finally be over in 2026. In interviews with BioSpace, Zymeworks’ CEO Ken Galbraith and Zai Lab’s ...
For one, interest rates are finally going down, with the Federal Reserve executing its latest cut on December 10. And ...
San Diego–based Ventyx Biosciences has what pharma wants, according to William Blair: two NLRP3 inhibitors for inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback